Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181
Merck Sharp & Dohme LLC
Antoine Adenis; Amit S Kulkarni; Gustavo C Girotto; Christelle de la Fouchardiere; Helene Senellart; Hanneke W M van Laarhoven; Wasat Mansoor; Raed Al-Rajabi; Josephine Norquist; Mayur Amonkar; Shailaja Suryawanshi; Pooja Bhagia; Jean-Philippe Metges